Overview of Reviews

You have free access to this content

Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome

  1. Laura Amato*,
  2. Silvia Minozzi,
  3. Marina Davoli

Editorial Group: Cochrane Drugs and Alcohol Group

Published Online: 15 JUN 2011

Assessed as up-to-date: 28 MAR 2011

DOI: 10.1002/14651858.CD008537.pub2


How to Cite

Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane Database of Systematic Reviews 2011, Issue 6. Art. No.: CD008537. DOI: 10.1002/14651858.CD008537.pub2.

Author Information

  1. ASL RM/E, Department of Epidemiology, Rome, Italy

*Laura Amato, Department of Epidemiology, ASL RM/E, Via di Santa Costanza, 53, Rome, 00198, Italy. amato@asplazio.it.

Publication History

  1. Publication Status: New
  2. Published Online: 15 JUN 2011

SEARCH

References

References to included reviews

  1. References to included reviews
  2. References to excluded reviews
  3. Additional references

References to excluded reviews

  1. References to included reviews
  2. References to excluded reviews
  3. Additional references
  • Fox C, Loughlin P, Cook C. Disulfiram for alcohol dependence. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD004331]
  • Pani PP, Trogu E, Amato L, Davoli M. Antidepressants for the treatment of depression in alcohol dependent individuals. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: 10.1002/14651858.CD008581]
  • Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for Alcohol Dependence. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD004332]
  • Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD001867.pub2]
  • Smith EJ, Lui S, Terplan M. Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007361.pub2]

Additional references

  1. References to included reviews
  2. References to excluded reviews
  3. Additional references
Atkins 2004
Choi 2005
  • Choi EA, Ki SW, Kim SE, Kim JW, Park JK. The Efficacy and Safety of Topiramate in the Treatment of Alcohol Withdrawal. Korean Database 2005;44(3):328-33.
Colombo 1995
  • Colombo G, Agabio R, Lobina C, Reali R, Fadda F, Gessa GL. Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges. Physiology & behavior 1995;57:105-11.
Colombo 1998
De Witte 2003
Dodd 2000
DSM-IV-R
  • AA.VV. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition revised.Washington, DC. American Psychiatric Association (Pub), 1995.
Frau 1995
  • Frau M, Colombo G, Marchese G, Stefanini E, Gessa GL. Differentaffinity of cortical GHB binding site in Sardinian alcohol-preferring (sP) and -non preferring (sNP) rats. Alcohol and Alcoholism 1995;30:133-7.
Gallimberti 1989
  • Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD, et al. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lamcet 1989;2:787-9.
Gallimberti 1992
Gann 2004
  • Gann H, Feige B, Cloot O, Van Wasen H, Zinzgraf D, Hohagen F, Riemann D. Polysomnography during withdrawal with chlormethiazole or placebo in alcohol dependent patients--a double-blind and randomised study  . Pharmacopsychiatry 2004;37(5):228-351.
Gillman 1986
Gillman 1996
  • Gilman S, Koeppe RA, Junck L, Kluin KJ, Lohman M, St Laurent RT. Benzodiazepine receptor binding in the cerebellum in multiple system atrophy and olivopontocerebellar atrophy studied with positron emission tomography. Advances in Neurology 1996;69:456-66.
Gillman 1998
Hasin 1990
  • Hasin DS, Grant B, Endicott J. The natural history of alcohol abuse: implications for definitions of alcohol use disorders. The American Journal of Psychiatry 1990;147(11):1537-41.
Holbrook 1999
  • Holbrook AM, Growther R, Lotter A, Cheng C, King D. Metaanalysis of benzodiazepine use in the treatment of acute alcohol withdrawal. Canadian Medical Association Journal 1999;282(11):1054-60.
Jadad 1998
  • Jadad AR, Cook DJ, Jones A, Klassen TP, Tugwell P, Moher M, et al. Methodology and reports of systematic reviews and meta-analyses:a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998;280(2):278-80.
Jermain 1992
Koethe 2007
Kohl 1998
Koob 1997
Leggio 2008
  • Leggio L, Kenna GA, Swift RM. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Progress in neuro-psychopharmacology & biological psychiatry 2008;32(5):1106-7.
Lejoyeux 1998
Mayo-Smith 1997
  • Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline.American Society of Addiction Medicine Working Group onPharmacological Management of Alcohol Withdrawal.. JAMA 1997;278(2):144-51.
McKay 2004
  • McKay A, Koranda A, Axen D. Using a symptom-triggered approach to manage patients in acute alcohol withdrawal.. Medical-Surgical Nurses 2004;13(1):15-20.
Moher 2007
Nutt 1999
Petty 1993
  • Petty F, Fulton M, Moeller FG, Kramer G, Wilson L, Fraser K, et al. Plasma gamma-aminobutyric acid (GABA) is low in alcoholics. Psychopharmacology Bulletin 1993;29(2):277-81.
Shane 1991
  • Shane SR, Flink EB. Magnesium deficiency in alcohol addiction and withdrawal. Magnesium and Trace Elements 1991;10:263-8.
Shea 2007
  • Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, HamelC, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007;15(7):10.
SIGN 2003
  • Scottish Intercollegiate Guidelines Network (SIGN). The management of harmful drinking and alcohol dependence in primary care. A national clinical guideline. www.sign.ac.uk 2003.
Slawecki 1999
  • Slawecki CJ, Somes C, Ehlers CL. Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y. Alcohol and Alcoholism 1999;34(3):289-99.
Sullivan 1989
Tsai 1995